| High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute … M Yanada, J Takeuchi, I Sugiura, H Akiyama, N Usui, F Yagasaki, ... Journal of clinical oncology 24 (3), 460-466, 2006 | 574 | 2006 |
| Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis M Yanada, K Matsuo, T Suzuki, H Kiyoi, T Naoe Leukemia 19 (8), 1345-1349, 2005 | 384 | 2005 |
| Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis M Yanada, K Matsuo, N Emi, T Naoe Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 264 | 2005 |
| Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL–positive acute … M Towatari, M Yanada, N Usui, J Takeuchi, I Sugiura, M Takeuchi, ... Blood 104 (12), 3507-3512, 2004 | 245 | 2004 |
| Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high‐risk acute lymphoblastic leukemia: a metaanalysis M Yanada, K Matsuo, T Suzuki, T Naoe Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 196 | 2006 |
| Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome M Yanada, T Matsushita, N Asou, Y Kishimoto, M Tsuzuki, Y Maeda, ... European journal of haematology 78 (3), 213-219, 2007 | 152 | 2007 |
| Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice K Ishiguro, K Kadomatsu, T Kojima, H Muramatsu, M Iwase, Y Yoshikai, ... Journal of Biological Chemistry 276 (50), 47483-47488, 2001 | 149 | 2001 |
| Prospective monitoring of BCR‐ABL1 transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib … M Yanada, I Sugiura, J Takeuchi, H Akiyama, A Maruta, Y Ueda, N Usui, ... British journal of haematology 143 (4), 503-510, 2008 | 124 | 2008 |
| Clinical significance of FLT3 in leukemia H Kiyoi, M Yanada, K Ozekia International journal of hematology 82, 85-92, 2005 | 104 | 2005 |
| Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia M Yanada, M Tsuzuki, H Fujita, K Fujimaki, S Fujisawa, K Sunami, ... Blood, The Journal of the American Society of Hematology 121 (16), 3095-3102, 2013 | 102 | 2013 |
| Acute myeloid leukemia in older adults M Yanada, T Naoe International journal of hematology 96, 186-193, 2012 | 86 | 2012 |
| Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic … M Yanada, K Yamamoto, N Emi, T Naoe, R Suzuki, H Taji, H Iida, ... Bone marrow transplantation 32 (8), 801-807, 2003 | 80 | 2003 |
| Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy Y Inamoto, M Ito, R Suzuki, T Nishida, H Iida, A Kohno, M Sawa, M Murata, ... Bone marrow transplantation 44 (1), 43-49, 2009 | 78 | 2009 |
| Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice M Yanada, T Kojima, K Ishiguro, Y Nakayama, K Yamamoto, T Matsushita, ... Blood, The Journal of the American Society of Hematology 99 (7), 2455-2458, 2002 | 73 | 2002 |
| Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors … M Yanada, N Emi, T Naoe, H Sakamaki, S Takahashi, N Hirabayashi, ... Bone marrow transplantation 34 (4), 331-337, 2004 | 72 | 2004 |
| Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated … M Yanada, J Takeuchi, I Sugiura, H Akiyama, N Usui, F Yagasaki, K Nishii, ... Haematologica 93 (2), 287-290, 2008 | 68 | 2008 |
| Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body … M Yanada, T Naoe, H Iida, H Sakamaki, T Sakura, H Kanamori, Y Kodera, ... Bone marrow transplantation 36 (10), 867-872, 2005 | 65 | 2005 |
| Long‐term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single‐center experience M Yanada, M Suzuki, K Kawashima, H Kiyoi, T Kinoshita, N Emi, H Saito, ... European journal of haematology 74 (5), 418-423, 2005 | 64 | 2005 |
| Tamibarotene as maintenance therapy for acute promyelocytic leukemia: results from a randomized controlled trial K Shinagawa, M Yanada, T Sakura, Y Ueda, M Sawa, J Miyatake, ... J Clin Oncol 32 (33), 3729-3735, 2014 | 63 | 2014 |
| Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of … M Yanada, J Mori, J Aoki, K Harada, S Mizuno, N Uchida, S Kurosawa, ... Leukemia & lymphoma 59 (3), 601-609, 2018 | 61 | 2018 |
